5 Best Shares to Buy Right Now in Australia

Henry Fung

Henry is a co-founder of MF & Co. Asset Management with over 20 years in financial services as a trader and investor, including the past 10 years advising clients and building quantitative trading systems. Henry also maintains a high conviction list of 5 stocks that you can get for free and has a free 5-day course on how professionals use quantitative strategies to find an edge. The concepts in the course are applied in the Quantitative Leveraged ETF L/S Strategy.


October 9, 2026

Finding the best shares to buy on the ASX requires more than just scanning a screener or chasing whatever is up this week. We focus on companies with strong competitive positioning, visible earnings growth, and a catalyst to drive the share price higher over the next 12 months. Every stock on this list has been through a full research process covering financials, industry dynamics, valuation, and management quality.

We update this page regularly as new research is published. The five stocks below represent our most recent work, ordered from newest to oldest. Each summary covers the key points of the investment case, with a link to the full write-up for those who want the detail.

Last updated 9 October 2026.

Stock Rating Price Target Last Price Upside Div Yield
Worley Ltd (ASX: WOR) Buy A$13.00 A$9.44 37.7% ~5.1%
Qantas Airways Ltd (ASX: QAN) Buy A$12.45 A$8.52 46.1% ~4.2%
Amcor Plc (ASX: AMC) Buy A$81.40 A$60.26 35.1% ~5.6%
Life360 Inc (ASX: 360) Buy A$30.95 A$20.34 52.2%
Breville Group Ltd (ASX: BRG) Buy A$37.90 A$31.07 22.0% ~1.4%

Our Top 5 Stocks To Buy Right Now on the ASX

Worley Ltd (ASX: WOR)

Buy, 12-month price target A$13.00 (31.8% upside), ~5.1% dividend yield, unfranked. Price target and upside based on prices at time of publication.


Worley is a global engineering and project delivery company serving the energy, chemicals and resources sectors, with over 40,000 people in more than 40 countries and FY26 aggregated revenue of A$12.0 billion. The September investor briefing was held in Houston for a reason. The Americas now generates A$6.2 billion of that revenue, a little under 52 per cent of the group, and it grew 17.3 per cent in FY26 while Europe, the Middle East and Africa fell 11.3 per cent and Asia Pacific fell 22.0 per cent. Underneath a flat group top line, professional services revenue fell from A$7,124 million to A$6,187 million while construction and fabrication rose to A$1,988 million and procurement rose 24.1 per cent to A$3,830 million. That is the company moving out of the drawing office and into the physical delivery of projects.

That shift is normally where engineering companies get hurt, and the contract mix is why we think this one is different. Reimbursable work was 77 per cent of FY26 revenue, and the annual report states plainly that Worley does not, and will not, take on competitively bid lump sum turnkey work. The 23 per cent that is fixed price is generally lump sum engineering, procurement and construction where the earlier phases are already done and the scope is known, plus short services contracts averaging under six months, and management has said it is not doing lump sum construction and is not taking lump sum risk for how subcontractors perform. Bookings rose 23 per cent to A$15.5 billion, backlog finished at A$13.8 billion with the company expecting over 62 per cent of it to convert within twelve months, and the CP2 Phase 2 expansion, expected to be larger than Phase 2 itself at 11.7 million tonnes a year, is not in that backlog figure yet.

At A$9.86 the stock trades on 12.6 times the 78.2 cents of underlying earnings it delivered in a year that carried A$58 million of Middle East disruption, and it sits about 2.6 per cent above its twelve month low of A$9.61 after falling roughly 29 per cent over the year. Institutional sell-side research has a 12 month price target of A$13.00, which is 31.8 per cent above that close. FY27 is guided to mid to high single digit growth in both aggregated revenue and underlying EBITA, and the share count came down 5.5 per cent in FY26 with another A$300 million buyback still running. The 5.1 per cent yield is unfranked, so for an investor able to use franking credits it is worth less after tax than a fully franked dividend of the same cash amount, but it is covered at 64 per cent of underlying earnings while you wait. Read the full article on Worley here.

Qantas Airways Ltd (ASX: QAN)

Buy, 12-month price target A$12.45 (32.6% upside), ~4.2% forward dividend yield, fully franked. Price target and upside based on prices at time of publication.


Qantas spent FY26 absorbing a $610 million increase in its fuel bill and $420 million of net earnings impact from the conflict in the Middle East, and still delivered $2.06 billion of underlying profit before tax on 96 cents of underlying earnings per share. The more interesting number in the result sits in the segment tables. Qantas International earned a 3.7 per cent operating margin on $9.9 billion of revenue, against 11.3 per cent for the domestic airline, 12.0 per cent for Jetstar and 21.7 per cent for Loyalty. The largest revenue line in the group contributes the least to earnings, which is also why it is the only division where fixing the structure is worth a lot of money.

The fix is a fleet program rather than a trading recovery. The A330s being retired carry around 9 to 11 per cent premium seating, while the A350-1000ULRs arriving for Project Sunrise are configured at 41 per cent and the incoming A350-1000LRs at more than 40 per cent. A premium seat generates roughly 3.8 times the unit revenue of an economy seat on the international network, and the newer aircraft burn less fuel per seat on top of it. Seventeen aircraft arrived in FY26 and up to 31 are due in FY27, the first Sunrise aircraft lands in April 2027, and the A380 fleet starts phasing out from calendar 2028.

Qantas has now put a date on where that leads, guiding the international segment to a 10 to 12 per cent operating margin from FY32 against a longstanding target of more than 8 per cent. That is a long wait and the aircraft have to arrive on schedule, but the mechanism is contracted rather than hoped for, and the near term revenue setup is strong with total unit revenue guided up 8 to 10 per cent in the first half of FY27 across both domestic and international on flat capacity. Loyalty grew earnings 12 per cent to $625 million and is guided up another 5 to 7 per cent in FY27, which pays part of the wait. Read the full article on Qantas here.

Amcor Plc (ASX: AMC)

Buy, 12-month price target A$81.40 (24.4% upside), ~5.6% forward dividend yield, unfranked. Price target and upside based on prices at time of publication.


Amcor has spent two years being judged on everything except its own volumes, and the June quarter finally put them back at the centre of the story. Comparable volumes rose about 0.5 per cent, the first clear positive inflection after a long stretch of destocking. Because the cost base is largely fixed, the earnings response was much larger than the volume move: group adjusted EBIT of US$836 million was up around 22 per cent on a comparable basis, with Flexibles up about 18 per cent and Rigids up about 24 per cent. Quarterly earnings per share of 123 US cents landed towards the top of the guided range.

Our Exclusive Top 5 Stock Picks

Five high conviction stocks that didn't make the public list. Backed by institutional research with significant upside potential. Subscribe for free access.

Invalid email address
By subscribing, you consent to receive communications from us. You can unsubscribe at any time.

The self-help is running ahead of plan alongside it. Amcor delivered about US$285 million of Berry synergies in the year to June against an original year-one expectation of US$260 million, and the three-year target of roughly US$650 million has been reaffirmed. Six small businesses have been agreed for sale for about US$500 million in total, five of which have closed, in a programme the company frames as portfolio optimisation. Net debt to EBITDA finished at 3.5 times with a targeted path to three times by the end of 2027.

The reason the stock has not re-rated on a better quarter is a genuinely messy outlook statement. Amcor is moving its year end from June to December, and guidance for the six-month transition period came in below where the market sat, although about 4 cents per share of that gap is the divested businesses, which consensus appears not to have stripped out yet. Guidance for calendar 2027 is for double-digit earnings growth, which on the bottom of the range is at or slightly ahead of consensus. A weaker six months followed by a year that is at least in line is an awkward thing to headline and a reasonable thing to own while being paid 5.6 per cent to wait. Read the full article on Amcor here.

Life360 Inc (ASX: 360)

Buy, 12-month price target A$30.95 (34.4% upside), no dividend. Price target and upside based on prices at time of publication.


Life360 grew revenue 38 per cent to US$159m in the June quarter and lifted adjusted EBITDA 53 per cent to US$31.1m, and the shares fell 19 per cent on the day. Two things drove that reaction. Monthly active user net additions of 4.6m came in below the pace the full-year guidance needs, and the headline profit beat was flattered by a one-off US$3.6m tariff benefit which, stripped out, leaves the quarter around 5 per cent ahead of consensus rather than 20 per cent.

The parts of the business Life360 controls most directly kept improving. Paying circles grew 185,000, a second-quarter record, with US conversion ticking up from 13.6 per cent to 13.8 per cent, and the Silver and Gold tiers were raised US$2 a month for new US subscribers. Advertising, built on the Nativo platform, more than quadrupled to US$22m and is now large enough to move the group result rather than being a rounding error.

Full-year guidance was retained at US$650-685m of revenue and US$130-140m of adjusted EBITDA, but the profit is weighted heavily to the fourth quarter, with management guiding to a margin above 22 per cent by then against 17 per cent underlying in the second quarter. That shape is the risk. A soft third quarter would leave very little room to recover, and user additions still need to step up from here. With the CDIs already down around 37 per cent over twelve months, we think the risk-reward leans favourably, but the next one or two quarters of user data will matter more than this print. Read the full article on Life360 here.

Breville Group Ltd (ASX: BRG)

Buy, 12-month price target A$37.90 (22.1% upside), ~1.4% forward dividend yield. Price target and upside based on prices at time of publication.


Breville Group sold off this year on fears that SharkNinja’s push into premium espresso machines would commoditise Breville’s best-performing category and squeeze the margin advantage that underpins its valuation. The category-level sales data tells a different story. Both premium brands, Breville and De’Longhi, grew their coffee appliance sales over the period SharkNinja gained share, while mass-market Keurig shrank. The share SharkNinja is taking looks to be coming out of the value end of the category, not out of Breville’s premium position, which is the part of the thesis that actually matters for the multiple the stock should carry.

The other overhang has been margin. FY26 is shaping up as the trough year for gross margin, with a full year of tariff costs absorbed into the cost of goods. Tariff refunds already flowing back, further manufacturing localisation, and a stronger Australian dollar are forecast to claw back around 80 basis points of gross margin by FY28, turning what looks like a structural problem today into a cyclical one that unwinds over the next two years.

On valuation, Breville trades at roughly its own ten-year average earnings multiple, a reasonable starting point rather than a bargain. That compares with Wesfarmers around 42 per cent above its own ten-year average, Nick Scali around 29 per cent above, and JB Hi-Fi around 24 per cent above theirs. Breville is the cheapest of that group relative to its own history, but at close to 29 times forward earnings it is not cheap in absolute terms, so the case here rests on the margin recovery playing out and the SharkNinja scare fading, rather than a re-rating from a depressed starting multiple. Read the full article on Breville here.

How We Pick Stocks for This List

Our selection process draws on institutional-grade research combined with our own analysis of each company’s competitive positioning, earnings trajectory, and valuation. We focus on ASX-listed businesses with clear catalysts, strong or improving returns on capital, and management teams with a track record of execution. Every stock on this list carries a Buy rating with a defined price target and investment thesis.

We are not trying to pick the next speculative runner. The companies featured here are profitable, have established market positions, and offer a risk-reward profile that we think makes sense for investors looking to build long-term wealth through Australian equities. We refresh this list as new research is completed, typically every few weeks.

If you would like to discuss any of these names, request a callback or call us on 1300 889 603.

This is general advice only. MF & Co Asset Management has not considered your personal financial needs, objectives or current situation. This information is not an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.

You May Also Like…

Subscribe

Want more Free Research?

Subscribe today for free and get an alert when we have new research and webinars.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.

Contact

Get In Touch

Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm

Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000

 

Share This